|
|
|
|
|
|
|
|
|
For Chiasma, 7+11=44
If nothing out of the ordinary happens, VC money gets to the start-up. At Chiasma, something out of the ordinary did happen.
Oral drug delivery system developer Chiasma reported this week that it has raised $11 million in venture capital. In November of 2006, Chiasma announced the largest funding so far for that year, as it raised $44 million in a third venture funding round. This week it reported that the same investors invested again, including ARCH Venture Partners, MPM Capital, 7 Health Ventures, Ofer Hi-Tech, and F2-Ventures.
|
|
|
| ©2010 The Trendlines Group Ltd. All rights reserved. This site contains material copyrighted by third parties.
|
|
|
